Parkside Financial Bank & Trust Grows Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Parkside Financial Bank & Trust raised its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 24.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,213 shares of the pharmacy operator’s stock after buying an additional 1,411 shares during the period. Parkside Financial Bank & Trust’s holdings in Walgreens Boots Alliance were worth $67,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of WBA. State Street Corp raised its holdings in shares of Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after purchasing an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after purchasing an additional 3,329,857 shares in the last quarter. Two Sigma Advisers LP bought a new stake in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $24,226,000. Thompson Siegel & Walmsley LLC raised its holdings in shares of Walgreens Boots Alliance by 15.5% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock valued at $62,325,000 after purchasing an additional 934,754 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after purchasing an additional 817,762 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

WBA has been the subject of several recent research reports. Bank of America boosted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Evercore ISI boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price objective for the stock from $11.00 to $9.00 in a research note on Friday. Truist Financial reduced their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Finally, Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $11.54.

Walgreens Boots Alliance Stock Down 4.9 %

WBA stock opened at $10.69 on Monday. The firm’s fifty day simple moving average is $10.50 and its 200-day simple moving average is $9.71. The company has a market capitalization of $9.23 billion, a P/E ratio of -1.04, a price-to-earnings-growth ratio of 1.31 and a beta of 0.65. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the prior year, the firm earned $0.66 EPS. The business’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.